Swiss Army Knife maker tries new tools to blunt Trump tariff blow

Swiss Army Knife manufacturer Victorinox is navigating significant challenges from a 39% U.S. tariff, which CEO Carl Elsener estimates will cost $13 million annually and make U.S. sales unprofitable. To maintain market share and avoid price hikes, the company is absorbing losses, pre-shipping substantial inventory to the U.S. to stabilize prices until 2026, and considering limited finishing operations in the U.S. to reduce dutiable value. Victorinox is also accelerating automation and diversifying into new markets like Latin America and Asia, while reaffirming its commitment to Swiss-based production due to brand heritage, a stance indicative of broader pressures on Swiss exporters.

Analysis

The 39% U.S. tariff on Swiss goods presents a significant financial challenge for Victorinox, projected to cost $13 million annually and render U.S. sales unprofitable. This tariff impacts 13% of Victorinox's 2024 sales, which totaled 417 million Swiss francs ($519 million), and reflects a broader pressure on Swiss manufacturers, with 45% reporting lower order intakes and profit margins already eroded by a 12% franc appreciation against the dollar. This situation contributes to the moderately negative sentiment observed across the sector.

In response, Victorinox is strategically absorbing losses and pre-shipping substantial inventory, including 200,000 Swiss Army Knives, to the U.S. to stabilize prices until 2026 and defend market share. The company is also exploring limited U.S. finishing operations to reduce dutiable value, accelerating automation at its Swiss plants, and actively diversifying into new markets like Latin America and Asia to lessen U.S. dependence. These actions demonstrate a proactive management approach to mitigate immediate tariff impacts.

Despite these efforts, the 'Swiss-made' label requirement, mandating 60% of manufacturing costs in Switzerland, constrains relocating production, forcing the company to accept losses to maintain brand heritage. This situation highlights the systemic risk for other Swiss exporters, including Novartis (NOVN) and Nestle (NESN), which could face similar tariff extensions, underscoring the cautious tone surrounding Swiss export-oriented businesses. The CEO's confidence in overcoming challenges is tempered by the ongoing financial strain.

Key Decisions for Investors

• Investors should closely monitor evolving U.S. trade policies and currency fluctuations, particularly the CHF/USD, as these significantly impact Swiss exporters' profitability and market access.
• Evaluate companies' strategies for supply chain flexibility, localized finishing, and market diversification, as these are critical for mitigating tariff risks and maintaining market share.
• Scrutinize companies' ability to absorb or pass on increased costs without eroding long-term profitability or losing competitive positioning, especially for brands reliant on origin-specific labeling.